Pre- and Post- Vitamin D supplementation comparative evaluation of clinical parameters of oral submucous fibrosis.
Not Applicable
- Conditions
- Health Condition 1: K135- Oral submucous fibrosis
- Registration Number
- CTRI/2023/06/054288
- Lead Sponsor
- Dr Raksha Jaiswal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Participants with OSMF stage II. (Chandramani More 2011 classification)
2. Participants with Serum Vitamin D levels of 15-30 ng/ml.
3. Participants willing for the study.
Exclusion Criteria
1. Participants with Hypertension, Diabetes Mellitus, and other systemic diseases.
2. Participants with a history of bone pathology.
3. Participants with Vitamin D supplementation.
4. Participants taking medications like corticosteroids and anticoagulants.
5. Strict Vegetarian.
6. Participants not willing for the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vitamin D supplementation is beneficial as an adjuvant in the treatment of Oral Submucous <br/ ><br>FibrosisTimepoint: Pre-treatment serum vitamin D level, interincisal mouth opening, burning sensation will be measured. These clinical parameters will be measured and recorded at baseline, 1st, 2nd, and 3rd month.
- Secondary Outcome Measures
Name Time Method Comparison of clinical parameters i.e interincisal mouth opening and burning sensation pre- and post- treatment with vitamin D supplementation in the management of Oral Submucous Fibrosis.Timepoint: baseline, 1,2,3 month.